InMed Pharmaceuticals Inc. Files Current Report
Ticker: INM · Form: 8-K · Filed: Jul 28, 2025 · CIK: 1728328
Sentiment: neutral
Topics: corporate-update, 8-K
TL;DR
InMed Pharmaceuticals Inc. filed an 8-K on 7/28/25, updating corporate info.
AI Summary
InMed Pharmaceuticals Inc. filed an 8-K on July 28, 2025, reporting a current event. The filing details the company's principal executive offices located at Suite 1445 - 885 W. Georgia Street, Vancouver, B.C., Canada, V6C 3E8. The report confirms the company's incorporation in British Columbia and its IRS Employer Identification No. 98-1428279.
Why It Matters
This 8-K filing serves as an official update on InMed Pharmaceuticals Inc.'s corporate information, including its principal executive offices and incorporation details.
Risk Assessment
Risk Level: low — This filing is a routine corporate update and does not contain material financial or operational news.
Key Players & Entities
- InMed Pharmaceuticals Inc. (company) — Filer
- July 28, 2025 (date) — Date of Report
- British Columbia (jurisdiction) — State of Incorporation
- Suite 1445 - 885 W. Georgia Street, Vancouver, B.C., Canada, V6C 3E8 (address) — Principal Executive Offices
- 98-1428279 (identifier) — IRS Employer Identification No.
FAQ
What is the exact name of the company filing this report?
The exact name of the company is InMed Pharmaceuticals Inc.
On what date was this 8-K report filed?
The report was filed on July 28, 2025.
In which jurisdiction was InMed Pharmaceuticals Inc. incorporated?
InMed Pharmaceuticals Inc. was incorporated in British Columbia.
What is the company's principal executive office address?
The principal executive office is located at Suite 1445 - 885 W. Georgia Street, Vancouver, B.C., Canada, V6C 3E8.
What is the IRS Employer Identification Number for InMed Pharmaceuticals Inc.?
The IRS Employer Identification Number is 98-1428279.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 28, 2025 regarding InMed Pharmaceuticals Inc. (INM).